ALNYLAM PHARMACEUTICALS, INC. Pension and Other Postretirement Benefits Cost (Reversal of Cost)
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Pension and Other Postretirement Benefits Cost (Reversal of Cost) of $3.27 million for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PensionAndOtherPostretirementBenefitExpense · last filed 2019-10-31
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for the quarter ending 2019-09-30 was $1.18M, a 8.40% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for the quarter ending 2019-06-30 was $1.00M, a 27.67% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for the quarter ending 2019-03-31 was $1.09M, a 15.61% increase year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for the quarter ending 2018-12-31 was -$453.00K, a 179.89% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for fiscal 2018 was $3.16M, a 37.23% increase from fiscal 2017.
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for fiscal 2017 was $2.30M, a 52.75% increase from fiscal 2016.
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for fiscal 2016 was $1.51M, a 53.15% increase from fiscal 2015.
- ALNYLAM PHARMACEUTICALS, INC. pension and other postretirement benefits cost (reversal of cost) for fiscal 2015 was $984.00K, a 42.20% increase from fiscal 2014.
| Period end | Pension and Other Postretirement Benefits Cost (Reversal of Cost) 3 month | Pension and Other Postretirement Benefits Cost (Reversal of Cost) 6 month | Pension and Other Postretirement Benefits Cost (Reversal of Cost) 9 month | Pension and Other Postretirement Benefits Cost (Reversal of Cost) 12 month |
|---|---|---|---|---|
| 2019-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.18M derived: sum of 2 quarters · filed 2019-10-31 | $3.27M 10-Q · filed 2019-10-31 | $2.81M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.09M 10-Q · filed 2019-08-06 | $1.64M derived: sum of 3 quarters · filed 2019-08-06 | $2.92M derived: sum of 4 quarters · filed 2019-10-31 |
| 2019-03-31 | $1.09M 10-Q · filed 2019-05-02 | $636.00K derived: sum of 2 quarters · filed 2019-05-02 | $1.92M derived: sum of 3 quarters · filed 2019-10-31 | $3.31M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-12-31 | -$453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $833.00K derived: sum of 2 quarters · filed 2019-10-31 | $2.22M derived: sum of 3 quarters · filed 2019-10-31 | $3.16M 10-K · filed 2019-02-14 |
| 2018-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $2.67M derived: sum of 2 quarters · filed 2019-10-31 | $3.61M 10-Q · filed 2019-10-31 | $4.18M derived: sum of 4 quarters · filed 2019-10-31 |
| 2018-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.33M 10-Q · filed 2019-08-06 | $2.89M derived: sum of 3 quarters · filed 2019-08-06 | $3.55M derived: sum of 4 quarters · filed 2019-08-06 |
| 2018-03-31 | $942.00K 10-Q · filed 2019-05-02 | $1.51M derived: sum of 2 quarters · filed 2019-05-02 | $2.17M derived: sum of 3 quarters · filed 2019-05-02 | $2.69M derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | $567.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $1.23M derived: sum of 2 quarters · filed 2019-02-14 | $1.75M derived: sum of 3 quarters · filed 2019-02-14 | $2.30M 10-K · filed 2019-02-14 |
| 2017-09-30 | $661.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.18M derived: sum of 2 quarters · filed 2018-11-07 | $1.74M 10-Q · filed 2018-11-07 | $2.04M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | $523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $1.07M 10-Q · filed 2018-08-02 | $1.38M derived: sum of 3 quarters · filed 2019-02-14 | $1.80M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | $551.00K 10-Q · filed 2018-05-04 | $856.00K derived: sum of 2 quarters · filed 2019-02-14 | $1.28M derived: sum of 3 quarters · filed 2019-02-14 | $1.73M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | $305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | $726.00K derived: sum of 2 quarters · filed 2019-02-14 | $1.18M derived: sum of 3 quarters · filed 2019-02-14 | $1.51M 10-K · filed 2019-02-14 |
| 2016-09-30 | $421.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $871.00K derived: sum of 2 quarters · filed 2017-11-07 | $1.20M 10-Q · filed 2017-11-07 | $1.41M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | $450.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $781.00K 10-Q · filed 2017-08-09 | $990.00K derived: sum of 3 quarters · filed 2018-02-15 | $1.24M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | $331.00K 10-Q · filed 2017-05-05 | $540.00K derived: sum of 2 quarters · filed 2018-02-15 | $794.00K derived: sum of 3 quarters · filed 2018-02-15 | $1.07M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | $209.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | $463.00K derived: sum of 2 quarters · filed 2018-02-15 | $737.00K derived: sum of 3 quarters · filed 2018-02-15 | $984.00K 10-K · filed 2018-02-15 |
| 2015-09-30 | $254.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $528.00K derived: sum of 2 quarters · filed 2016-11-03 | $775.00K 10-Q · filed 2016-11-03 | $954.00K derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | $274.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $521.00K 10-Q · filed 2016-08-04 | $700.00K derived: sum of 3 quarters · filed 2017-02-15 | |
| 2015-03-31 | $247.00K 10-Q · filed 2016-05-04 | $426.00K derived: sum of 2 quarters · filed 2017-02-15 | ||
| 2014-12-31 | $179.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $692.00K 10-K · filed 2017-02-15 | ||
| 2014-09-30 | $513.00K 10-Q · filed 2015-11-09 | |||
| 2013-12-31 | $449.00K 10-K · filed 2016-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |